1.	Pharmacokinetics Study of Liposomal Paclitaxel in Humans Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: LPS-PK-01-2008, NCT00606515
2.	Phase II Study of PNU-93914 in Patients With Locally Advanced or Metastatic Esophageal Carcinoma (Summary Last Modified 08/2001) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-00124, P-UPJOHN-914-ONC-0355-009, NCI-G01-1946, NCT00016900
3.	Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LEP-ETU 202, NCT01190982
4.	Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LEP-ETU-101-R03, NCT00080418
5.	Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LEP-ETU-102A, NCT00100139